Thanks for emailing that article!
Louis Cantor, MD discusses Glaucoma 360 New Horizons Forum, an annual meeting presented by Glaucoma Research Foundation designed to speed the development of new therapies and diagnostics for glaucoma patients.
Louis Cantor, MD:Glaucoma 360, more than any other meeting that I’ve been to, brings together a really diverse group of individuals interested in the care of patients with glaucoma. Everyone from physicians to industry to patients and philanthropists are all in the same room. I’ve not experienced that before in any other meeting.
Glaucoma 360 offers a unique opportunity to interact with colleagues and to learn from them. One of the things that I always enjoy about the meetings is the interaction that I have with my colleagues and the chance to learn from them. There’s so much that’s going on in glaucoma that it’s difficult to keep up and to really be abreast of the newest advances. A meeting like Glaucoma 360 really helps that to happen.
What has changed in the field of glaucoma in recent years?
Well there are several changes that are occurring, some of which I spoke about this morning at the New Horizons meeting of Glaucoma 360. We’re understanding the brain in glaucoma, we’re redefining the optic nerve and the structural changes that happen when there’s damage in the eye from glaucoma. We’re learning how to measure vision and visual fields in a completely different way that’s more objective and that is better.
We are learning more about how to treat and some of the treatment strategies beyond lowering pressure, such as neuroprotection, and we’re seeing this explosion of new devices and approaches from surgery. All of these and many other areas in our basic understanding of glaucoma are really offering a great future.
Louis B. Cantor, MD was keynote speaker at the 2013 Glaucoma 360 New Horizons Forum. He is Chair and Professor of Ophthalmology, Jay C. and Lucile L. Kahn Professor of Glaucoma Research and Education, and Director of the Glaucoma Service at the Eugene and Marilyn Glick Eye Institute, Indiana University School of Medicine in Indianapolis.
Last reviewed on January 16, 2018